Preparation of Conotoxin-Encapsulated Chitosan Nanoparticles and Evaluation of Their Skin Permeability

Haigang Li,JiPeng Yao,Yong Guo,Jingjing Huo,Haijuan Zhang,Zengtao Zhang,Jinchuan Zhou,Xiaowei Shi,Zhilong Zhao,Jinlong Zhao,Chun Zhang
DOI: https://doi.org/10.2139/ssrn.4135091
2022-01-01
SSRN Electronic Journal
Abstract:µ-Conotoxin CnIIIC (conotoxin, CTX) has potent anti-wrinkle properties, but its structure precludes its penetration of the stratum corneum through passive diffusion. In this study, to enhance the skin penetrability of CTX, chitosan nanoparticles (CTX-NPs) were prepared using the ionic cross-linking method. The particle size, surface potential, morphology, encapsulation rate, drug release mechanism, in vivo and in vitro transdermal effects, skin irritation test and cytotoxicity of the CTX-NPs were characterized and evaluated. Results showed that the CTX-NPs were spherical and well dispersed, with a particle size of 123.9 ± 22.2 nm, a zeta potential of 40.5 ± 1.9 mV, and an encapsulation efficiency of 95.6 ± 1.3%. In vitro release studies showed that the release behavior of CTX-NPs in a pH 5.0 acetate buffer followed zero-order kinetics. Both in vivo and in vitro transdermal studies indicated that CTX-NPs produced better transdermal effects than CTX. Furthermore, CTX-NPs induced less skin irritation and cytotoxicity.
What problem does this paper attempt to address?